Dr Reddy's shares rise as brokerages assess Q2 results
Shares rose in morning trade as brokerages highlighted a margin recovery and better-than-expected September-quarter profitability. Nomura kept its Buy rating but cut its target price; Citi raised its target, and Jefferies upgraded the stock.